Cadila Healthcare informs about analyst meet

22 May 2021 Evaluate
Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cadila Healthcare has informed that post results Q&A session through teleconference has been scheduled on May 27, 2021 at 4:30 pm. Sharvil Patel, Managing Director of the Company would be hosting the call. The call will be conducted through the audio webcast format.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

919.90 -4.45 (-0.48%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×